Combination studies of RA with the HDAC inhibitor trichostatin A, (TSA), resulted in anti-tumorigenic effect in SH-SY5Y and SK-N-BE cells, suggesting that this combined therapy could be useful to inhibit NB progression [54]. This evidence concerns the gene HDAC9 and neuroblastoma.